ArticleAnnals of the rheumatic diseases2014

MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome.

Naomi I Maria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.